Filter Results:
(594)
Show Results For
- All HBS Web
(1,124)
- People (2)
- News (256)
- Research (594)
- Events (3)
- Multimedia (10)
- Faculty Publications (423)
Show Results For
- All HBS Web
(1,124)
- People (2)
- News (256)
- Research (594)
- Events (3)
- Multimedia (10)
- Faculty Publications (423)
Sort by
- February 2011 (Revised October 2018)
- Case
ALAC International
By: Richard S. Ruback and Royce Yudkoff
ALAC was a small importer of specialty industrial chemicals. The case explores the different financing alternatives to facilitate the company's explosive growth in working capital. At the end of 2009, the company was awarded the United States distributorship for the... View Details
Ruback, Richard S., and Royce Yudkoff. "ALAC International." Harvard Business School Case 211-065, February 2011. (Revised October 2018.)
- 2024
- Working Paper
Gastrointestinal Endoscopy--Without Cutting In: Case Histories of Transformational Advances
By: Amar Bhidé, Srikant M. Datar and Katherine Stebbins
This case history describes how endoscopy transformed the diagnosis of ulcers, cancerous polyps, and other alimentary canal diseases and enabled “minimally invasive” surgeries to treat such diseases. Specifically, we chronicle how: 1) flexible glass fiber endoscopes... View Details
Keywords: Health Care and Treatment; Technological Innovation; Innovation Strategy; Technology Adoption; Collaborative Innovation and Invention; Innovation and Invention; Governing Rules, Regulations, and Reforms
Bhidé, Amar, Srikant M. Datar, and Katherine Stebbins. "Gastrointestinal Endoscopy--Without Cutting In: Case Histories of Transformational Advances." Harvard Business School Working Paper, No. 20-005, July 2019. (Revised May 2024.)
- July 2015 (Revised March 2021)
- Case
Proxy Contest at DuPont
By: Jay W. Lorsch and Emily McTague
On January 9, 2015, Nelson Peltz of Trian Fund Management launched a proxy fight for four out of the twelve seats on the DuPont board. The fund had previously published a public letter addressed to shareholders outlining its proposal to break the company into three... View Details
Keywords: Board Of Directors; Hedge Fund; Activist Investing; Activist Investors; Proxy Fight; Corporate Governance; Governing and Advisory Boards; Investment Activism; Chemical Industry; United States
Lorsch, Jay W., and Emily McTague. "Proxy Contest at DuPont." Harvard Business School Case 416-005, July 2015. (Revised March 2021.)
- June 2015
- Article
You Need an Innovation Strategy
By: Gary P. Pisano
Why is it so hard to build and maintain the capacity to innovate? The reason is not simply a failure to execute but a failure to articulate an innovation strategy that aligns innovation efforts with the overall business strategy. Without such a strategy, companies will... View Details
Keywords: Innovation Strategy
Pisano, Gary P. "You Need an Innovation Strategy." Harvard Business Review 93, no. 6 (June 2015): 44–54.
- January 2009
- Case
VOSS Artesian Water from Norway
By: Youngme E. Moon, Gail J. McGovern, Daniela Beyersdorfer and Vincent Marie Dessain
VOSS is a Norwegian bottled water company that produces one of the world's purest drinking waters, sold at an ultra-premium price in a sleek cylindrical glass bottle of minimalist design. In the U.S. (the company's primary market), VOSS's high-end brand presence is... View Details
Keywords: Brands and Branding; Marketing Channels; Marketing Strategy; Product; Luxury; Food and Beverage Industry; Norway; United States
Moon, Youngme E., Gail J. McGovern, Daniela Beyersdorfer, and Vincent Marie Dessain. "VOSS Artesian Water from Norway." Harvard Business School Case 509-040, January 2009.
- July 2020 (Revised March 2021)
- Case
Board Diversity at Amazon (A)
By: Aiyesha Dey and Anu Atluru
The case revolves around the decisions that the board of directors of ecommerce giant Amazon would need to make in response to the controversial letter that activist shareholder CtW investment group sent to Amazon’s shareholders, urging them to vote in favor of a... View Details
Keywords: Board Of Directors; Boards; Governing and Advisory Boards; Diversity; Gender; Race; United States
Dey, Aiyesha, and Anu Atluru. "Board Diversity at Amazon (A)." Harvard Business School Case 121-012, July 2020. (Revised March 2021.)
- September 1996 (Revised December 1997)
- Case
Cytec Industries' Spin-Off (A): Sink or Swim?
In the wake of market pressure to restructure, American Cyanamid spun off its poorly performing Chemicals Unit into a new publicly traded corporation, Cytec Industries. In addition to weak operations, Cytec inherited the bulk of Cyanamid's environmental and... View Details
Keywords: Organizational Change and Adaptation; Management Practices and Processes; Restructuring; Performance Improvement; Chemical Industry; United States
Wruck, Karen, and Sherry P. Roper. "Cytec Industries' Spin-Off (A): Sink or Swim?" Harvard Business School Case 897-053, September 1996. (Revised December 1997.)
- July 1997 (Revised April 1998)
- Case
Chase Manhattan Corporation: The Making of America's Largest Bank
By: Stuart C. Gilson and Cedric Escalle
Chase Bank and Chemical Bank intend to merge, producing the largest commercial bank in the United States, the fourth largest in the world. Projected financial benefits under the merger reflect significant planned reduction in operating costs, including 17,000 employee... View Details
Keywords: Commercial Banking; Profit; Corporate Strategy; Value Creation; Restructuring; Negotiation; Mergers and Acquisitions; Risk and Uncertainty; Resignation and Termination; Revenue; Banking Industry; United States
Gilson, Stuart C., and Cedric Escalle. "Chase Manhattan Corporation: The Making of America's Largest Bank." Harvard Business School Case 298-016, July 1997. (Revised April 1998.)
- September 1993
- Case
Rhone-Poulenc (B)
Rhone-Poulenc, France's largest chemical firm, has achieved a major position in the United States as the result of an ambitious series of acquisitions. As it expanded in the United States from 1986 to 1990, Rhone-Poulenc management sought to take a "hands-off" approach... View Details
Keywords: Organizational Change and Adaptation; Multinational Firms and Management; Organizational Structure; Chemical Industry; France; United States
Rosenzweig, Philip M. "Rhone-Poulenc (B)." Harvard Business School Case 394-041, September 1993.
- September 1986 (Revised February 2007)
- Case
Solagen: Process Improvement in the Manufacture of Gelatin at Kodak
By: Dorothy A. Leonard and Brian DeLacey
Kodak must decide whether to make a major investment in a production facility designed around a new technique for producing the gelatin critical to so many film and paper products. Currently, gelatin making is an arcane art, unchanged in 150 years and heavily dependent... View Details
Keywords: Arts; Buildings and Facilities; Factories, Labs, and Plants; Experience and Expertise; Engineering; Investment; Time Management; Production; Research and Development; Semiconductor Industry
Leonard, Dorothy A., and Brian DeLacey. "Solagen: Process Improvement in the Manufacture of Gelatin at Kodak." Harvard Business School Case 687-020, September 1986. (Revised February 2007.)
- July 2021
- Teaching Note
The Carlyle Group: Carving Out Atotech
Teaching Note for HBS Case No. 321-153. On January 31, 2017, The Carlyle Group ("Carlyle") closed its $3.2 billion acquisition of Atotech, an international Specialty Chemicals and Equipment company. In Carlyle's Washington, DC headquarters, the US-based deal... View Details
- October 1992 (Revised August 1994)
- Case
Allied-Signal: Managing the Hazardous Waste Liability Risk
By: Richard H.K. Vietor and Edward Prewitt
Allied-Signal, Inc., one of the world's oldest chemical companies and today a diversified conglomerate, is liable for clean-up costs of old hazardous waste sites. These costs are substantial: reserves grew to nearly $500 million in 1991. Attempting to avoid further... View Details
Keywords: Wastes and Waste Processing; Environmental Sustainability; Programs; Cost Management; Policy; Government Legislation; Factories, Labs, and Plants; Governance Compliance; Legal Liability; Chemical Industry; United States; Europe
Vietor, Richard H.K., and Edward Prewitt. "Allied-Signal: Managing the Hazardous Waste Liability Risk." Harvard Business School Case 793-044, October 1992. (Revised August 1994.)
- October 1990 (Revised April 1991)
- Case
RU 486 (A)
Describes the factors faced by Roussel UCLAF, a French drug company, in deciding whether and how to market a controversial new drug, RU 486, which is often called "the French abortion pill." Roussel's decision involved its relations with the French government, its... View Details
Keywords: Judgments; Ethics; Product Launch; Negotiation; Outcome or Result; Performance; Business and Government Relations; Health Industry; Pharmaceutical Industry; France; Germany; United States
Badaracco, Joseph L., Jr. "RU 486 (A)." Harvard Business School Case 391-050, October 1990. (Revised April 1991.)
- September 2011
- Case
China Development Bank
By: Li Jin, Matthew Preble and Aldo Sesia
In May 2011, Chairman Chen Yuan of the China Development Bank (CDB) was thinking back on CDB's financing of a major project between Petroleo Brasileiro SA (Petrobras), Brazil's state-owned oil and gas producer and China Petroleum & Chemical Corporation (Sinopec), one... View Details
Keywords: International Finance; Emerging Markets; Energy Sources; Banks and Banking; Energy Industry; Brazil; China
Jin, Li, Matthew Preble, and Aldo Sesia. "China Development Bank." Harvard Business School Case 212-001, September 2011.
- September 1993
- Case
Rhone-Poulenc (A)
Rhone-Poulenc, France's largest chemical firm, with revenues of more than $7 billion in 1985, seeks to dramatically expand its presence in the United States. From 1986 to 1990, Rhone-Poulenc undertakes 18 separate acquisitions, ranging from small entrepreneurial firms... View Details
Rosenzweig, Philip M. "Rhone-Poulenc (A)." Harvard Business School Case 394-040, September 1993.
- 2022
- Article
Missing Novelty in Drug Development
By: Joshua Krieger, Danielle Li and Dimitris Papanikolaou
We provide evidence that risk aversion leads pharmaceutical firms to underinvest in radical innovation. We introduce a new measure of drug novelty based on chemical similarity and show that firms face a risk-reward trade-off: novel drug candidates are less likely to... View Details
Keywords: Drug Development; Risk Aversion; Research and Development; Innovation and Invention; Investment; Pharmaceutical Industry
Krieger, Joshua, Danielle Li, and Dimitris Papanikolaou. "Missing Novelty in Drug Development." Review of Financial Studies 35, no. 2 (February 2022): 636–679.
- April 2010
- Article
Low-energy Limit for Tunnelling Subject to an Eckart Potential Barrier
By: Samuel H Lipoff and Dudley R Herschbach
For two-body s-wave collisions subject to tunnelling though an Eckart potential barrier, cross-sections and rate coefficients in the low-energy regime can be evaluated in analytic form. These provide criteria for approach to the Wigner limit and a generic plot... View Details
Lipoff, Samuel H., and Dudley R Herschbach. "Low-energy Limit for Tunnelling Subject to an Eckart Potential Barrier." Molecular Physics 108, nos. 7-9 (April 2010): 1133–1143.
- January 2018
- Supplement
Interview with Case Protagonist Wen Li
By: Willy C. Shih
In today's global economy, what are the factors that go into production location choice? This case is set in the world's largest automotive glass producer as it expands from China into the United States. To meet a very aggressive cost target, management is faced with... View Details
Keywords: Globalization Of Supply Chain; Production Management; Production; Globalization; Global Strategy; Auto Industry; China; United States
Shih, Willy C. "Interview with Case Protagonist Wen Li." Harvard Business School Multimedia/Video Supplement 618-704, January 2018.
- January 1990 (Revised October 1993)
- Case
Monsanto's March into Biotechnology (A)
By: Gary P. Pisano
Very early in the history of biotechnology (about 1979), Monsanto made a major commitment to move into this field. This case recounts the history from the point of view of the eminent scientist hired to head up corporate R&D. He took Monsanto from a very traditional... View Details
Keywords: History; Transition; Agriculture and Agribusiness Industry; Agriculture and Agribusiness Industry
Pisano, Gary P. "Monsanto's March into Biotechnology (A)." Harvard Business School Case 690-009, January 1990. (Revised October 1993.)
- Article
Where Do Resources Come from? The Role of Idiosyncratic Situations
By: Gautam Ahuja and Riitta Katila
In this paper, we examine the emergence of resources. Our analysis of technological capability acquisition by global U.S.-based chemical firms shows that the emergence of resources is inherently evolutionary. We find that path-creating search that generates resource... View Details
Ahuja, Gautam, and Riitta Katila. "Where Do Resources Come from? The Role of Idiosyncratic Situations." Special Issue on The Global Acquisition, Leverage, and Protection of Technological Competencies. Strategic Management Journal 25, nos. 8-9 (August–September 2004): 887–907.